The Lily Foundation

Homepage: thelilyfoundation.org.uk

Alternate name: Lily

ROR: 00daznq87

OpenAlex ID: I4405268269

Research priorities for mitochondrial disorders: Current landscape and patient and professional views

2022 · Rhys H. Thomas, Amy Hunter, et al. · Journal of Inherited Metabolic Disease · 15

280th ENMC International Workshop: The ERN EURO-NMD mitochondrial diseases working group; diagnostic criteria and outcome measures in primary mitochondrial myopathies. Hoofddorp, the Netherlands, 22-24 November 2024

2025 · Michelangelo Mancuso, Piervito Lopriore, et al. · Neuromuscular Disorders · 11

2000–2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future

2026 · Amel Karaa, Maria Isabel G. Lopez Sanchez, et al. · Therapeutic Advances in Rare Disease · 1

Survival and causes of death in primary mitochondrial diseases

2026 · Katherine R. Schon, Jeanette Aston, et al. · Genome Medicine

Patients’ lived experience of thymidine kinase 2 deficiency: the online survey-based assessment of TK2d patient perspectives study

2026 · Amel Karaa, Asha Hareendran, et al. · Therapeutic Advances in Rare Disease

The Lily Foundation: supporting patients, raising awareness and funding research into mitochondrial diseases

2025 · Liz Curtis, Maria E. O'Hanlon, et al. · FEBS Letters

The top ten research priorities for rare mitochondrial diseases: results of a patient/health professional priority setting partnership

2021 · Marcela Votruba, Lyndsey Butterworth, et al. · Acta Ophthalmologica

Works count: 7

Citation count: 27